The Indian healthcare industry is increasingly recognizing artificial intelligence (AI) as a crucial strategic element, facilitating advanced treatments and promoting systemic efficiency throughout the sector.
Argo Biopharmaceutical, a biotechnology firm in the clinical stage that specializes in the development of next-generation siRNA therapeutics, has announced the establishment of an additional strategic partnership with Novartis concerning several
Mankind Pharma, India's fourth largest pharma company, has received approval from CDSCO to conduct a phase 1 clinical trial for its new JAK-1 inhibitor, MKP11093. The orally available drug molecule, which has been developed at Mankind Research...
.jpeg "NPPA sets Ceiling Price for Gufic Meropenem Dual Chamber Bag")
The National Pharmaceutical Pricing Authority (NPPA) has handed a special ceiling price for the product of Meropenem Powder for Injection in dual chamber bags by Gufic Biosciences Limited
India's prominent drug manufacturers Sun Pharmaceutical Industries and Lupin Ltd are advancing toward making affordable anti-obesity pills as the country faces a rapidly growing obesity epidemic. According to a report, the Drugs Controller General...
In this modern age of Artificial Intelligence, it is important to provide the new age AI driven solutions to the society in the healthcare sector also. In a strategic move to strengthen healthcare innovation in India
.jpeg "Eli Lilly Wins USFDA Breakthrough for Olomorasib in Lung Cancer Therapy")
Eli Lilly and Company has been given the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for olomorasib combined with anti-PD-1 therapy Keytruda
Poly Medicure, India's largest medical device company announced its acquisition of 90% of the PendraCare Group, including PendraCare Holdings and Wellinq Medical, from Wellinq Holdings B.V. The deal has an enterprise value of €18.3 million...
.jpeg "Sanofi Highlights 31 Abstracts on Inflammatory Respiratory Diseases at ERS")
Sanofi's approved and pipeline medications aimed at addressing significant care gaps in chronic inflammatory respiratory diseases will be showcased at the European Respiratory Society (ERS) International Congress.
.jpeg "Glenmark Initiates Global Phase 3 Trial for Novel Lung Cancer Drug")
Glenmark Pharmaceuticals has also begun a global Phase 3 clinical trial with Envafolimab, a new medication to treat patients with third stage non-small cell lung cancer (NSCLC). The shift highlights the increasing role of India in late-stage drug dev
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")